glp-1 and parkinson's disease Beyond insulin: The Intriguing role of in GLP-1 and Parkinson's Disease: Research,

[17] In people with high cardiovascular risk, liraglutide has been shown to reduce the risk for first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke

Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes

The second study with 426 patients randomly assigned to TAK-875, placebo, or glimepiride treatment groups showed significant reductions in HbA1c levels from baseline in the TAK-875 (6.25 to 50 mg) and glimepiride (4 mg) treatment groups compared with the placebo group at week 12 [60]

even though insulin sensitivity is improved when you're leaner, your genetics haven't changed, and if your hormonal blueprint leans more towards "carb sensitive" you'll still have to pay close attention to diet and exercise to stay insulin sensitive and subsequently, lean

When I needed a receipt for FSA, it was readily available in my account